# FDA 483 - Merck Biodevelopment - Unknown Date

Source: https://www.globalkeysolutions.net/records/483/merck-biodevelopment/95a0dafc-f45d-4c31-952d-38596d3cd78f

> FDA 483 for Merck Biodevelopment on Unknown Date. Product: drugs. Access full analysis and detailed observations.

---

## Details

- Record Type: 483
- Company Name: Merck Biodevelopment
- Product Type: drugs
- Office Name: Division of Clinical Evidence and Analysis 1 (Clinical Policy and Quality)

## Related Documents

- [483 - 2022-10-14](https://www.globalkeysolutions.net/records/483/merck-biodevelopment/4b27c7d5-a22d-46b2-9a5c-76ab2b1394ea)

## Related Officers

- [Chen Sun Ph.D., Biologist](https://www.globalkeysolutions.net/people/chen-sun-phd-biologist/23c466aa-654e-427d-bb43-3cef2a4b818c)
- [Richard Ledwidge, Ph.D., Biologist](https://www.globalkeysolutions.net/people/richard-ledwidge-phd-biologist/51161c1e-63da-4f24-bf8b-ecc1398c9dbe)
- [Matthew Casale, Investigator](https://www.globalkeysolutions.net/people/matthew-casale-investigator/6d265e1b-4375-4702-af40-8315ff4a267d)

Company: https://www.globalkeysolutions.net/companies/merck-biodevelopment/3db28a71-687c-4930-ade4-7ab5d59dce23

Office: https://www.globalkeysolutions.net/offices/division-of-clinical-evidence-and-analysis-1-clinical-policy-and-quality/5f95da17-30bb-423f-b892-5ea041823fbd